| Symbol |
Name |
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
AANAT
|
aralkylamine N-acetyltransferase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTB
|
actin, beta
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR1
|
activin A receptor, type I
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ACYP2
|
acylphosphatase 2, muscle type
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM28
|
ADAM metallopeptidase domain 28
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTSL4
|
ADAMTS-like 4
|
|
ADAP1
|
ArfGAP with dual PH domains 1
|
|
ADCY1
|
adenylate cyclase 1 (brain)
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO1
|
argonaute RISC catalytic component 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHCY
|
adenosylhomocysteinase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDOA
|
aldolase A, fructose-bisphosphate
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH2
|
alkB, alkylation repair homolog 2 (E. coli)
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANKRD17
|
ankyrin repeat domain 17
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANP32C
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member C
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA2
|
annexin A2
|
|
ANXA4
|
annexin A4
|
|
ANXA7
|
annexin A7
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
APC
|
adenomatous polyposis coli
|
|
APCS
|
amyloid P component, serum
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC2
|
apolipoprotein C-II
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP10
|
aquaporin 10
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARG2
|
arginase 2
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARTN
|
artemin
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B2M
|
beta-2-microglobulin
|
|
B3GALT5
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BANP
|
BTG3 associated nuclear protein
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BGN
|
biglycan
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP1
|
bone morphogenetic protein 1
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPER
|
BMP binding endothelial regulator
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BSN
|
bassoon presynaptic cytomatrix protein
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTF3
|
basic transcription factor 3
|
|
BTG3
|
BTG family, member 3
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
C3
|
complement component 3
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA4
|
carbonic anhydrase IV
|
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
|
CA5B
|
carbonic anhydrase VB, mitochondrial
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CAMK1
|
calcium/calmodulin-dependent protein kinase I
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAND1
|
cullin-associated and neddylation-dissociated 1
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPNS1
|
calpain, small subunit 1
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBX1
|
chromobox homolog 1
|
|
CBX5
|
chromobox homolog 5
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC85B
|
coiled-coil domain containing 85B
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNG1
|
cyclin G1
|
|
CCNK
|
cyclin K
|
|
CCNT1
|
cyclin T1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD163
|
CD163 molecule
|
|
CD180
|
CD180 molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD247
|
CD247 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD37
|
CD37 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD48
|
CD48 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD7
|
CD7 molecule
|
|
CD70
|
CD70 molecule
|
|
CD72
|
CD72 molecule
|
|
CD81
|
CD81 molecule
|
|
CD86
|
CD86 molecule
|
|
CD9
|
CD9 molecule
|
|
CD93
|
CD93 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK14
|
cyclin-dependent kinase 14
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CENPA
|
centromere protein A
|
|
CERK
|
ceramide kinase
|
|
CERS1
|
ceramide synthase 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHAD
|
chondroadherin
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CIDEA
|
cell death-inducing DFFA-like effector a
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CIRBP
|
cold inducible RNA binding protein
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLASP2
|
cytoplasmic linker associated protein 2
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLDN1
|
claudin 1
|
|
CLEC10A
|
C-type lectin domain family 10, member A
|
|
CLEC11A
|
C-type lectin domain family 11, member A
|
|
CLEC2D
|
C-type lectin domain family 2, member D
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS2
|
COP9 signalosome subunit 2
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYGD
|
crystallin, gamma D
|
|
CS
|
citrate synthase
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CST3
|
cystatin C
|
|
CST6
|
cystatin E/M
|
|
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSF
|
cathepsin F
|
|
CTSG
|
cathepsin G
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTTN
|
cortactin
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXXC1
|
CXXC finger protein 1
|
|
CYCS
|
cytochrome c, somatic
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
CYTH2
|
cytohesin 2
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAZL
|
deleted in azoospermia-like
|
|
DCK
|
deoxycytidine kinase
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCP1A
|
decapping mRNA 1A
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX1
|
DEAD (Asp-Glu-Ala-Asp) box helicase 1
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB4A
|
defensin, beta 4A
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DIS3
|
DIS3 exosome endoribonuclease and 3'-5' exoribonuclease
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DNAJC5
|
DnaJ (Hsp40) homolog, subfamily C, member 5
|
|
DND1
|
DND microRNA-mediated repression inhibitor 1
|
|
DNM1L
|
dynamin 1-like
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRAM2
|
DNA-damage regulated autophagy modulator 2
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DST
|
dystonin
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP10
|
dual specificity phosphatase 10
|
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F6
|
E2F transcription factor 6
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EBNA1BP2
|
EBNA1 binding protein 2
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECHS1
|
enoyl CoA hydratase, short chain, 1, mitochondrial
|
|
EDEM1
|
ER degradation enhancer, mannosidase alpha-like 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFNB1
|
ephrin-B1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
EGR3
|
early growth response 3
|
|
EIF1AX
|
eukaryotic translation initiation factor 1A, X-linked
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELL
|
elongation factor RNA polymerase II
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENOX2
|
ecto-NOX disulfide-thiol exchanger 2
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENPP7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA3
|
EPH receptor A3
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESM1
|
endothelial cell-specific molecule 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV1
|
ets variant 1
|
|
ETV4
|
ets variant 4
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
EXOSC5
|
exosome component 5
|
|
EXTL2
|
exostosin-like glycosyltransferase 2
|
|
EXTL3
|
exostosin-like glycosyltransferase 3
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR1B
|
Fc fragment of IgG, high affinity Ib, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCRL5
|
Fc receptor-like 5
|
|
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF16
|
fibroblast growth factor 16
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL2
|
four and a half LIM domains 2
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXC2
|
forkhead box C2
|
|
FOXF1
|
forkhead box F1
|
|
FOXM1
|
forkhead box M1
|
|
FOXN3
|
forkhead box N3
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUS
|
FUS RNA binding protein
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAK
|
cyclin G associated kinase
|
|
GALK1
|
galactokinase 1
|
|
GART
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
|
GAS6
|
growth arrest-specific 6
|
|
GAST
|
gastrin
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GCG
|
glucagon
|
|
GCGR
|
glucagon receptor
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF2
|
growth differentiation factor 2
|
|
GEMIN2
|
gem (nuclear organelle) associated protein 2
|
|
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1
|
|
GGA3
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 3
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRX3
|
glutaredoxin 3
|
|
GMCL1
|
germ cell-less, spermatogenesis associated 1
|
|
GMFG
|
glia maturation factor, gamma
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GOLM1
|
golgi membrane protein 1
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPC1
|
glypican 1
|
|
GPC3
|
glypican 3
|
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like)
|
|
GPR87
|
G protein-coupled receptor 87
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRB10
|
growth factor receptor-bound protein 10
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM4
|
glutamate receptor, metabotropic 4
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSR
|
glutathione reductase
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1
|
|
GYG1
|
glycogenin 1
|
|
GYG2
|
glycogenin 2
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HCN1
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC6
|
histone deacetylase 6
|
|
HDC
|
histidine decarboxylase
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HES6
|
hes family bHLH transcription factor 6
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HHIP
|
hedgehog interacting protein
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIGD1A
|
HIG1 hypoxia inducible domain family, member 1A
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HIVEP3
|
human immunodeficiency virus type I enhancer binding protein 3
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXA1
|
homeobox A1
|
|
HOXA13
|
homeobox A13
|
|
HOXB4
|
homeobox B4
|
|
HOXB5
|
homeobox B5
|
|
HOXB7
|
homeobox B7
|
|
HP
|
haptoglobin
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPSE
|
heparanase
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPA14
|
heat shock 70kDa protein 14
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTT
|
huntingtin
|
|
HYOU1
|
hypoxia up-regulated 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA10
|
interferon, alpha 10
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNA8
|
interferon, alpha 8
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGKC
|
immunoglobulin kappa constant
|
|
IHH
|
indian hedgehog
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17D
|
interleukin 17D
|
|
IL17RD
|
interleukin 17 receptor D
|
|
IL18
|
interleukin 18
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL31
|
interleukin 31
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
ILK
|
integrin-linked kinase
|
|
ING2
|
inhibitor of growth family, member 2
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INHBA
|
inhibin, beta A
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB6
|
integrin, beta 6
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITM2A
|
integral membrane protein 2A
|
|
IVL
|
involucrin
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIAA0368
|
KIAA0368
|
|
KIF14
|
kinesin family member 14
|
|
KIF21A
|
kinesin family member 21A
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLF8
|
Kruppel-like factor 8
|
|
KLK1
|
kallikrein 1
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
KRT8
|
keratin 8, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila)
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LAT
|
linker for activation of T cells
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LDB1
|
LIM domain binding 1
|
|
LDHB
|
lactate dehydrogenase B
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LHX4
|
LIM homeobox 4
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIPC
|
lipase, hepatic
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LIPG
|
lipase, endothelial
|
|
LMAN1L
|
lectin, mannose-binding, 1 like
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOX
|
lysyl oxidase
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LTF
|
lactotransferrin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LZTFL1
|
leucine zipper transcription factor-like 1
|
|
MACROD1
|
MACRO domain containing 1
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAGED1
|
melanoma antigen family D1
|
|
MALT1
|
MALT1 paracaspase
|
|
MAOA
|
monoamine oxidase A
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K10
|
mitogen-activated protein kinase kinase kinase 10
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAT1A
|
methionine adenosyltransferase I, alpha
|
|
MB
|
myoglobin
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCRS1
|
microspherule protein 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MED1
|
mediator complex subunit 1
|
|
MED14
|
mediator complex subunit 14
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP4
|
microfibrillar-associated protein 4
|
|
MGLL
|
monoglyceride lipase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR100
|
microRNA 100
|
|
MIR10B
|
microRNA 10b
|
|
MIR122
|
microRNA 122
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR126
|
microRNA 126
|
|
MIR1291
|
microRNA 1291
|
|
MIR141
|
microRNA 141
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR16-2
|
microRNA 16-2
|
|
MIR17
|
microRNA 17
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR181C
|
microRNA 181c
|
|
MIR18A
|
microRNA 18a
|
|
MIR195
|
microRNA 195
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR23B
|
microRNA 23b
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26B
|
microRNA 26b
|
|
MIR27B
|
microRNA 27b
|
|
MIR31
|
microRNA 31
|
|
MIR320A
|
microRNA 320a
|
|
MIR376C
|
microRNA 376c
|
|
MIR451A
|
microRNA 451a
|
|
MIR494
|
microRNA 494
|
|
MIR504
|
microRNA 504
|
|
MIR519B
|
microRNA 519b
|
|
MIR574
|
microRNA 574
|
|
MIR584
|
microRNA 584
|
|
MIR92A2
|
microRNA 92a-2
|
|
MIR98
|
microRNA 98
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7E
|
microRNA let-7e
|
|
MIRLET7F1
|
microRNA let-7f-1
|
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP24
|
matrix metallopeptidase 24 (membrane-inserted)
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MRC1
|
mannose receptor, C type 1
|
|
MRC2
|
mannose receptor, C type 2
|
|
MRS2
|
MRS2 magnesium transporter
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MST1
|
macrophage stimulating 1
|
|
MSTN
|
myostatin
|
|
MSX2
|
msh homeobox 2
|
|
MTA1
|
metastasis associated 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTSS1
|
metastasis suppressor 1
|
|
MUC3
|
intestinal mucin-like
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MXRA8
|
matrix-remodelling associated 8
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
MYOCD
|
myocardin
|
|
NABP2
|
nucleic acid binding protein 2
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBAS
|
neuroblastoma amplified sequence
|
|
NBN
|
nibrin
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NELFE
|
negative elongation factor complex member E
|
|
NES
|
nestin
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2IP
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFYB
|
nuclear transcription factor Y, beta
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFG
|
Nerve growth factor, gamma subunit
|
|
NKRF
|
NFKB repressing factor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-2
|
NK3 homeobox 2
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1L1
|
NPC1-like 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRD1
|
nardilysin (N-arginine dibasic convertase)
|
|
NRG1
|
neuregulin 1
|
|
NRL
|
neural retina leucine zipper
|
|
NRP1
|
neuropilin 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
NUMB
|
numb homolog (Drosophila)
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OGN
|
osteoglycin
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORM1
|
orosomucoid 1
|
|
OSMR
|
oncostatin M receptor
|
|
OTC
|
ornithine carbamoyltransferase
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX4
|
paired box 4
|
|
PCDH1
|
protocadherin 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCOLCE
|
procollagen C-endopeptidase enhancer
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDE8A
|
phosphodiesterase 8A
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHB
|
pyruvate dehydrogenase (lipoamide) beta
|
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PENK
|
proenkephalin
|
|
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHACTR1
|
phosphatase and actin regulator 1
|
|
PI16
|
peptidase inhibitor 16
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIK3R6
|
phosphoinositide-3-kinase, regulatory subunit 6
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
|
PITHD1
|
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLA2G2D
|
phospholipase A2, group IID
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD2
|
phospholipase D2
|
|
PLG
|
plasminogen
|
|
PLIN2
|
perilipin 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLK3
|
polo-like kinase 3
|
|
PLOD2
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
|
|
PLS3
|
plastin 3
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PLVAP
|
plasmalemma vesicle associated protein
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PODXL
|
podocalyxin-like
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
POLR1B
|
polymerase (RNA) I polypeptide B, 128kDa
|
|
PON1
|
paraoxonase 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRG4
|
proteoglycan 4
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD3
|
protein kinase D3
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRM2
|
protamine 2
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PRSS3
|
protease, serine, 3
|
|
PRTN3
|
proteinase 3
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTPRS
|
protein tyrosine phosphatase, receptor type, S
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PTRH2
|
peptidyl-tRNA hydrolase 2
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVR
|
poliovirus receptor
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYY
|
peptide YY
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51AP1
|
RAD51 associated protein 1
|
|
RAD54B
|
RAD54 homolog B (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASL11A
|
RAS-like, family 11, member A
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RECQL4
|
RecQ protein-like 4
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHAG
|
Rh-associated glycoprotein
|
|
RHCG
|
Rh family, C glycoprotein
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RLN1
|
relaxin 1
|
|
RLN2
|
relaxin 2
|
|
RNF2
|
ring finger protein 2
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPL11
|
ribosomal protein L11
|
|
RPL19
|
ribosomal protein L19
|
|
RPL26
|
ribosomal protein L26
|
|
RPL29
|
ribosomal protein L29
|
|
RPL30
|
ribosomal protein L30
|
|
RPL5
|
ribosomal protein L5
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPSA
|
ribosomal protein SA
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RTN4
|
reticulon 4
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SAA1
|
serum amyloid A1
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SBNO1
|
strawberry notch homolog 1 (Drosophila)
|
|
SCAP
|
SREBF chaperone
|
|
SCARA3
|
scavenger receptor class A, member 3
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCG2
|
secretogranin II
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN2B
|
sodium channel, voltage gated, type II beta subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1D
|
sodium channel, non voltage gated 1 delta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SCTR
|
secretin receptor
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SDC4
|
syndecan 4
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SEC61B
|
Sec61 beta subunit
|
|
SEC62
|
SEC62 homolog (S. cerevisiae)
|
|
SEC63
|
SEC63 homolog (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFTPC
|
surfactant protein C
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIAE
|
sialic acid acetylesterase
|
|
SIGLEC15
|
sialic acid binding Ig-like lectin 15
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3
|
|
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC25A14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC25A5P8
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 pseudogene 8
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC30A10
|
solute carrier family 30, member 10
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14
|
|
SLC39A4
|
solute carrier family 39 (zinc transporter), member 4
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC5A7
|
solute carrier family 5 (sodium/choline cotransporter), member 7
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2
|
|
SLC8A3
|
solute carrier family 8 (sodium/calcium exchanger), member 3
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLN
|
sarcolipin
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNW1
|
SNW domain containing 1
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPG21
|
spastic paraplegia 21 (autosomal recessive, Mast syndrome)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPN
|
sialophorin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSTR2
|
somatostatin receptor 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
ST8SIA3
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
|
|
STAB2
|
stabilin 2
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK25
|
serine/threonine kinase 25
|
|
STK3
|
serine/threonine kinase 3
|
|
STMN1
|
stathmin 1
|
|
STOX1
|
storkhead box 1
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
SULT4A1
|
sulfotransferase family 4A, member 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein
|
|
SYTL1
|
synaptotagmin-like 1
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBX2
|
T-box 2
|
|
TBX21
|
T-box 21
|
|
TBX5
|
T-box 5
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TCF12
|
transcription factor 12
|
|
TCF3
|
transcription factor 3
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TESK1
|
testis-specific kinase 1
|
|
TET3
|
tet methylcytosine dioxygenase 3
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFCP2
|
transcription factor CP2
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TKTL1
|
transketolase-like 1
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLK1
|
tousled-like kinase 1
|
|
TLN1
|
talin 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM132D
|
transmembrane protein 132D
|
|
TMEM243
|
transmembrane protein 243, mitochondrial
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF19
|
tumor necrosis factor receptor superfamily, member 19
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNIP3
|
TNFAIP3 interacting protein 3
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI1
|
troponin I type 1 (skeletal, slow)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53I11
|
tumor protein p53 inducible protein 11
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPD52
|
tumor protein D52
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRA
|
T cell receptor alpha locus
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAIP
|
TRAF interacting protein
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIM11
|
tripartite motif containing 11
|
|
TRIM15
|
tripartite motif containing 15
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRNAG1
|
tRNA glycine1 (anticodon CCC)
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPC7
|
transient receptor potential cation channel, subfamily C, member 7
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTC19
|
tetratricopeptide repeat domain 19
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
UBB
|
ubiquitin B
|
|
UBD
|
ubiquitin D
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBE4A
|
ubiquitination factor E4A
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UCA1
|
urothelial cancer associated 1 (non-protein coding)
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UNG
|
uracil-DNA glycosylase
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
UPP1
|
uridine phosphorylase 1
|
|
USF1
|
upstream transcription factor 1
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)
|
|
USP15
|
ubiquitin specific peptidase 15
|
|
USP2
|
ubiquitin specific peptidase 2
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
USP8
|
ubiquitin specific peptidase 8
|
|
UTS2B
|
urotensin 2B
|
|
UTS2R
|
urotensin 2 receptor
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
VSNL1
|
visinin-like 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF3
|
WAS protein family, member 3
|
|
WDTC1
|
WD and tetratricopeptide repeats 1
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WSB1
|
WD repeat and SOCS box containing 1
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB25
|
zinc finger and BTB domain containing 25
|
|
ZCCHC12
|
zinc finger, CCHC domain containing 12
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZFYVE16
|
zinc finger, FYVE domain containing 16
|
|
ZHX1
|
zinc fingers and homeoboxes 1
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF300
|
zinc finger protein 300
|
|
ZNF521
|
zinc finger protein 521
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
